Cargando…
KLF4 is a key determinant in the development and progression of cerebral cavernous malformations
Cerebral cavernous malformations (CCMs) are vascular malformations located within the central nervous system often resulting in cerebral hemorrhage. Pharmacological treatment is needed, since current therapy is limited to neurosurgery. Familial CCM is caused by loss‐of‐function mutations in any of C...
Autores principales: | Cuttano, Roberto, Rudini, Noemi, Bravi, Luca, Corada, Monica, Giampietro, Costanza, Papa, Eleanna, Morini, Marco Francesco, Maddaluno, Luigi, Baeyens, Nicolas, Adams, Ralf H, Jain, Mukesh K, Owens, Gary K, Schwartz, Martin, Lampugnani, Maria Grazia, Dejana, Elisabetta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718159/ https://www.ncbi.nlm.nih.gov/pubmed/26612856 http://dx.doi.org/10.15252/emmm.201505433 |
Ejemplares similares
-
Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice
por: Boulday, Gwénola, et al.
Publicado: (2011) -
Wnt Activation of Immortalized Brain Endothelial Cells as a Tool for Generating a Standardized Model of the Blood Brain Barrier In Vitro
por: Paolinelli, Roberta, et al.
Publicado: (2013) -
Endothelial cell clonal expansion in the development of cerebral cavernous malformations
por: Malinverno, Matteo, et al.
Publicado: (2019) -
Mapping endothelial-cell diversity in cerebral cavernous malformations at single-cell resolution
por: Orsenigo, Fabrizio, et al.
Publicado: (2020) -
Inflammation and neutrophil extracellular traps in cerebral cavernous malformation
por: Yau, Anthony C. Y., et al.
Publicado: (2022)